Optimized methods for delivery of DSRNA targeting the PCSK9 gene

Details for Australian Patent Application No. 2009241591 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Kotelianski, Victor E.; De Fougerolles, Antonin; Fitzgerald, Kevin; Akinc, Akin

Agent FB Rice

Pub. Number AU-A-2009241591

PCT Pub. Number WO2009/134487

Priority 61/039,083 24.03.08 US; 61/076,548 27.06.08 US; 61/188,765 11.08.08 US; 61/024,968 31.01.08 US

Filing date 30 January 2009

Wipo publication date 5 November 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/134487 Priority application(s): WO2009/134487

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009241598-Bow hold training device

2009241589-Dual variable domain immunoglobulins and uses thereof